NCT03064048View on ClinicalTrials.gov

Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Argininosuccinate Lyase DeficiencyUrea Cycle DisorderUrea Cycle Disorders, InbornArgininosuccinic Aciduria
Interventions
DIETARY_SUPPLEMENT

Neo-ASA

Dietary supplement with nitric oxide in the form of a lozenge called Neo-ASA.

DIETARY_SUPPLEMENT

Placebo

Dietary supplement with no nitric oxide in the form of a lozenge to look and taste like the dietary supplement Neo-ASA

Trial Locations (1)

77030

Baylor College of Medicine, Houston

Sponsors

Collaborators (1)

Neogenis Laboratories
All Listed Sponsors
collaborator

Rare Diseases Clinical Research Network

NETWORK

collaborator

Neogenis Laboratories

OTHER

lead

Baylor College of Medicine

OTHER

NCT03064048 - Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD | Biotech Hunter | Biotech Hunter